600276 恒瑞醫藥
按盤價 
69.650 -1.440 (-2.026%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.559 | 14.739 | 10.991 | 10.728 | 13.831 |
| 總資產報酬率 ROA (%) | 7.874 | 13.493 | 9.988 | 9.570 | 12.245 |
| 投入資產回報率 ROIC (%) | 8.496 | 14.572 | 10.648 | 10.332 | 13.551 | 邊際利潤分析 |
| 銷售毛利率 (%) | 86.581 | 86.249 | 84.552 | 83.612 | 85.556 |
| 營業利潤率 (%) | 32.732 | 26.767 | 21.516 | 19.327 | 18.007 |
| 息稅前利潤/營業總收入 (%) | 30.517 | 23.574 | 18.356 | 16.440 | 15.936 |
| 淨利潤/營業總收入 (%) | 28.264 | 22.645 | 18.746 | 17.932 | 17.309 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.240 | 97.307 | 98.683 | 88.905 | 92.080 |
| 價值變動淨收益/利潤總額(%) | 1.764 | 1.575 | -2.302 | 11.689 | 5.590 |
| 營業外收支淨額/利潤總額(%) | -2.137 | -4.476 | -5.202 | -3.615 | -4.445 | 償債能力分析 |
| 流動比率 (X) | 13.495 | 9.719 | 12.252 | 8.500 | 8.875 |
| 速動比率 (X) | 12.750 | 9.054 | 11.346 | 7.827 | 8.168 |
| 資產負債率 (%) | 6.143 | 8.069 | 6.284 | 9.341 | 9.409 |
| 帶息債務/全部投入資本 (%) | -0.030 | -0.054 | 0.972 | 4.048 | 1.586 |
| 股東權益/帶息債務 (%) | -334,099.590 | -184,059.235 | 10,140.508 | 2,350.520 | 6,155.215 |
| 股東權益/負債合計 (%) | 1,513.175 | 1,125.227 | 1,470.724 | 955.631 | 947.456 |
| 利息保障倍數 (X) | -19.955 | -11.518 | -8.756 | -7.428 | -12.216 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 56.745 | 65.025 | 87.444 | 89.038 | 67.442 |
| 存貨周轉天數 (天) | 212.692 | 221.301 | 243.282 | 250.552 | 201.115 |
| 備註： | 即時報價更新時間為 19/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
